Interest of Spo2 in early detection of the pre-IRCO phase during stable COPD classified in GOLD2 (2019)
Dr. M.Bentrad *
*Corresponding Author: M.Bentrad *, private pulmonology practice, Annaba, Algeria.
Received Date: November 07, 2020
Publication Date: December 01, 2020
Introduction and Definition:
Traditionally, chronic obstructive respiratory failure (CIRI) is defined as a Pao2-lt; 60 mmHg, it is the final stage of any chronic obstructive pulmonary disease (COPD). The lung becomes incapable of ensuring satisfactory oxygenation of arterial blood.
Early detection of the pre-IRCO phase during the evolution of any stable-looking COPD will set the warning of the unexpected occurrence of life-threatening stage respiratory failure that interferes with normal breathing, i.e. Measuring peripheral oxygen saturation (Spo2) appears to be a marker of great interest that will allow the selection of COPDs that have potential that can become complicated and quickly reach the stage of respiratory.
Epidemiological Recall:
According to WHO:
Interest in the study:
Periodic stress assessment of peripheral oxygen saturation (Spo2) in patients with stable COPD classified in Gold 2 (2016) .
Materials and Methods:
Material:
Effort evaluation of Spo2 in a sample of 95 patients followed at our level for COPD Gold 2 for 2 years.
Female sex is excluded from this study for reasons of social customs,
Age between 42 and 65 years old.
No comorbidity associated with it.
D2/ Method. normal Spo2 values between 95% and 100%.
Stress test: 15-minute brisk walking, recovery oxygen therapy in patients with signs of acute hypoxia with significant flexing - 3 points.
Findings: Clinically:
2a - there are two groups:
Group 1: represents 11% of the cohort
Spo2's significant decline, a loss of 5 points on average below the lower limit of the safety interval - 95-100%
group 2: represents 84% of the cohort
Presents to spirometry a DEM25-75% on average - 60% No significant change in Spo2 to stress.
2b- recovery after oxygen therapy involved the first group whose Spo2 is declined significantly to 95%, withclinicalsigns of acute hypoxi
Finding: A slow, persistent response of Spo2 to the underside of the safety interval (95-100%) despite clinical improvement.
Graphic illustration
The underlying graph illustrates the variations in Spo2 before and after stress in both groups:
Before the effort: The blue curve: includes 2 points:
1- Top point represents the average of resting Spo2 of 84 patients at DEM 25-75% - 60% lower point represents the average of Spo2 of the 11 patients at DEM 25-75% - 25%
Refer Figure-1
Discussion:
At rest the Spo2 remains stable for a long time during the evolution of COPD, this stability seems to be maintained by the revascularization of dead spaces, chest distension and secondly by the reactional polyglobulia that results in a countervailing element of great role.
During the effort, the Spo2 degrades according to the degree of limitation of the distal airflow, its persistence below the safety interval despite an adequate oxygenation sign of a possible transition to respiratory failure of insidious evolution, hence the interest of a gasometry.
Conclusion:
The severe and irreversible insidious progression of the chronic obstructive pulmonary disease to obstructive chronic respiratory failure prompts us to periodically monitor Peripheral oxygen saturation (Spo2 after stress) in stable-looking COPDs that have a severe limitation of distal airflow (DEM 25-75%) this easy and innocuous practice will allow us to detect early the pre-respiratory failure phase and thus improve quality of life and decrease mortality rates.
References
1.Definition and epidemiological data: WHO 2016, Curves and tables word Pulmonary Functional Exploration (Jack Wanger, pulmonary physiology Unit national Jewish center for immunology and respiratory medicine.
2.Definition and normal values ?? of Spo2 (health medicine 2019. medical records (cabinet pneumology Dr Bentrad 2018-2019.pulse oximeter and Spo2 (efurgences September 2018 posting 63859)
Volume 1 Issue 4 December 2020
©All rights reserved by Dr. Mouloud Bentrad.
Figure 1